See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
cornea and attachment of the iris to the cornea, which causes blurred vision. It may also be associated with clouding of the lens of the eye (cataracts) or other lens abnormalities. The cause of Peters anomaly is unknown; it may be caused by genetic factors (including alterations of several genes, like the FOXC1, PAX6, PITX2, or CYP1B1 genes, environmental factors, or both. The critical event must occur in the first trimester of pregnancy during the formation of the anterior chamber. Most cases of Peters anomaly are sporadic or inherited in an autosomal recessive pattern. Some few cases might be inherited in an autosomal dominant pattern. Peters anomaly may occur as an isolated ocular abnormality or in association with other ocular defects. Peters anomaly is a feature of the Krause-Kivlin syndrome and the Peters-plus syndrome. Treatment depends on the problems that the patient has and may include glaucoma treatment or surgery to correct the cataracts or other lens abnormalities.Peters anomaly is a disorder of the eye which involves thinning and clouding of the
Last updated: 9/11/2015
- Peters anomaly. Genetics Home Reference. January, 2014; http://ghr.nlm.nih.gov/condition/peters-anomaly. Accessed 9/11/2015.
- Arunagiri G. Peters Anomaly. Medscape Reference. November 14, 2014; http://emedicine.medscape.com/article/1200372-overview. Accessed 9/11/2015.
- Peters Anomaly. Online Mendelian Inheritance in Man (OMIM). April 26, 2013; http://omim.org/entry/604229.
- Genetics Home Reference (GHR) contains information on Peters anomaly. This website is maintained by the National Library of Medicine.
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.